{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T23:06:31Z","timestamp":1776639991700,"version":"3.51.2"},"reference-count":66,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinical-colorectal-cancer.com","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.clcc.2024.05.007","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T02:05:15Z","timestamp":1716257115000},"page":"309-317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Peritoneal Carcinomatosis in Colorectal Cancer: Review and Update of Current Clinical Data"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5830-9797","authenticated-orcid":false,"given":"S.","family":"Blaj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Leebmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Babucke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Acs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Piso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clcc.2024.05.007_bib0001","unstructured":"https:\/\/www.wcrf.org\/cancer-trends\/colorectal-cancer-statistics\/. Accessed October, 2023."},{"key":"10.1016\/j.clcc.2024.05.007_bib0002","unstructured":"http:\/\/gco.iarc.fr. Accessed October, 2023."},{"issue":"27","key":"10.1016\/j.clcc.2024.05.007_bib0003","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.3748\/wjg.v25.i27.3484","article-title":"Colorectal peritoneal metastases: optimal management review","volume":"25","author":"S\u00e1nchez-Hidalgo","year":"2019","journal-title":"WJG"},{"key":"10.1016\/j.clcc.2024.05.007_bib0004","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.amjsurg.2016.03.008","article-title":"Peritoneal carcinomatosis of colorectal cancer: novel clinical and molecular outcomes","volume":"213","author":"Massalou","year":"2017","journal-title":"Am J Surg"},{"key":"10.1016\/j.clcc.2024.05.007_bib0005","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/01.sla.0000197702.46394.16","article-title":"Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies","volume":"243","author":"Koppe","year":"2006","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.clcc.2024.05.007_bib0006","doi-asserted-by":"crossref","first-page":"S206","DOI":"10.21037\/jgo-20-133","article-title":"Systemic therapy in addition to cytoreduction and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: recent insights from clinical studies and translational research","volume":"12","author":"Bakkers","year":"2021","journal-title":"J Gastrointest Oncol"},{"issue":"12","key":"10.1016\/j.clcc.2024.05.007_bib0007","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.3390\/jcm11123406","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: a summary of key clinical trials","volume":"11","author":"Turner","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.clcc.2024.05.007_bib0008","doi-asserted-by":"crossref","first-page":"29765","DOI":"10.1038\/srep29765","article-title":"Patterns of metastasis in colon and rectal cancer","volume":"6","author":"Riihim\u00e4ki","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.clcc.2024.05.007_bib0009","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","article-title":"Peritoneal carcinomatosis from non- gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study","volume":"88","author":"Sadeghi","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.clcc.2024.05.007_bib0010","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archsurg.136.7.773","article-title":"Surgical palliation at a cancer center: incidence and outcomes","volume":"136","author":"Krouse","year":"2001","journal-title":"Arch Surg"},{"issue":"10","key":"10.1016\/j.clcc.2024.05.007_bib0011","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S2468-1253(19)30239-0","article-title":"Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial","volume":"4","author":"Klaver","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.clcc.2024.05.007_bib0012","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1200\/JCO.22.02644","article-title":"Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): 5-year results of a randomized multicenter trial","volume":"42","author":"Zwanenburg","year":"2024","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.clcc.2024.05.007_bib0013","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S1470-2045(20)30322-3","article-title":"Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study","volume":"21","author":"Go\u00e9r\u00e9","year":"2020","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.clcc.2024.05.007_bib0014","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1245\/s10434-021-10049-3","article-title":"The landmark series: surgical treatment of colorectal cancer peritoneal metastases","volume":"28","author":"Bijelic","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.clcc.2024.05.007_bib0015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12885-018-4096-0","article-title":"HIPECT4: multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma","volume":"18","author":"Arjona-S\u00e1nchez","year":"2018","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.clcc.2024.05.007_bib0016","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamasurg.2023.0662","article-title":"Efficacy and safety of intraoperative hyperthermic intraperitoneal chemotherapy for locally advanced colon cancer: a phase 3 randomized clinical trial","volume":"158","author":"Arjona-S\u00e1nchez","year":"2023","journal-title":"JAMA Surg"},{"issue":"20","key":"10.1016\/j.clcc.2024.05.007_bib0017","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer","volume":"21","author":"Verwaal","year":"2003","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.clcc.2024.05.007_bib0018","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","article-title":"8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer","volume":"15","author":"Verwaal","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clcc.2024.05.007_bib0019","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejca.2015.09.017","article-title":"Cytoreductive surgery and intraperitoneal chemotherapy versus systemic chemotherapy for colorectal peritoneal metastases: a randomised trial","volume":"53","author":"Cashin","year":"2016","journal-title":"Eur J Cancer"},{"issue":"33","key":"10.1016\/j.clcc.2024.05.007_bib0020","doi-asserted-by":"crossref","first-page":"55657","DOI":"10.18632\/oncotarget.17497","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectal cancer: a systematic review and meta-analysis of current evidence","volume":"8","author":"Huang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.clcc.2024.05.007_bib0021","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Quenet","year":"2021","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.clcc.2024.05.007_bib0022","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1186\/s12885-022-09572-7","article-title":"GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases","volume":"22","author":"Pereira","year":"2022","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.clcc.2024.05.007_bib0023","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.clcc.2018.07.011","article-title":"Perioperative systemic chemotherapy, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy in patients with colorectal peritoneal metastasis: results of the prospective multicenter phase 2 COMBATAC trial","volume":"17","author":"Glockzin","year":"2018","journal-title":"Clin Colorectal Cancer"},{"issue":"8","key":"10.1016\/j.clcc.2024.05.007_bib0024","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1001\/jamasurg.2021.1642","volume":"156","author":"Rovers","year":"2021","journal-title":"JAMA Surg"},{"issue":"2","key":"10.1016\/j.clcc.2024.05.007_bib0025","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejso.2017.10.216","article-title":"Safety of intraperitoneal Mitomycin C versus intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and HIPEC","volume":"44","author":"van Eden","year":"2018","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.clcc.2024.05.007_bib0026","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.21873\/invivo.12840","article-title":"Selection criteria for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with special emphasis on laparoscopy as an efficient tool","volume":"36","author":"Acs","year":"2022","journal-title":"In Vivo"},{"key":"10.1016\/j.clcc.2024.05.007_bib0027","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.suronc.2020.02.010","article-title":"Adding diagnostic laparoscopy to computed tomography for the evaluation of peritoneal metastases in patients with colorectal cancer: a retrospective cohort study","volume":"33","author":"Leimk\u00fchler","year":"2020","journal-title":"Surg Oncol"},{"issue":"5","key":"10.1016\/j.clcc.2024.05.007_bib0028","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/bjs.8679","article-title":"Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer","volume":"99","author":"Segelman","year":"2012","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.clcc.2024.05.007_bib0029","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1245\/s10434-012-2473-5","article-title":"Definition of patients presenting a high risk of developing peritoneal carcinomatosis after curative surgery for colorectal cancer: a systematic review","volume":"20","author":"Honor\u00e9","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.clcc.2024.05.007_bib0030","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1245\/s10434-013-3461-0","article-title":"Peritoneal carcinomatosis in t4 colorectal cancer: occurrence and risk factors","volume":"21","author":"van Santvoort","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.clcc.2024.05.007_bib0031","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/DCR.0000000000000412","article-title":"Epidemiology, management, and survival of peritoneal carcinomatosis from colorectal cancer: a population-based study","volume":"58","author":"Quere","year":"2015","journal-title":"Dis Colon Rectum"},{"issue":"8","key":"10.1016\/j.clcc.2024.05.007_bib0032","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.ejso.2013.10.001","article-title":"Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer","volume":"40","author":"van Gestel","year":"2014","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1016\/j.clcc.2024.05.007_bib0033","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/SLA.0000000000002899","article-title":"Mutations of RAS\/RAF proto-oncogenes impair survival after cytoreductive surgery and hipec for peritoneal metastasis of colorectal origin","volume":"268","author":"Schneider","year":"2018","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.clcc.2024.05.007_bib0034","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1080\/0284186X.2018.1487581","article-title":"The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic pattern","volume":"57","author":"Prasanna","year":"2018","journal-title":"Acta Oncol"},{"issue":"1","key":"10.1016\/j.clcc.2024.05.007_bib0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/bjc.2016.161","article-title":"Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers","volume":"115","author":"Kim","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clcc.2024.05.007_bib0036","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/629496","article-title":"Epithelial-mesenchymal transition and somatic alteration in colorectal cancer with and without peritoneal carcinomatosis","volume":"2014","author":"Shelygin","year":"2014","journal-title":"Biomed Res Int"},{"issue":"11","key":"10.1016\/j.clcc.2024.05.007_bib0037","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nm.3967","article-title":"The consensus molecular subtypes of colorectal cancer","volume":"21","author":"Guinney","year":"2015","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.clcc.2024.05.007_bib0038","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","volume":"17","author":"Franko","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clcc.2024.05.007_bib0039","series-title":"Tumors of the female pelvic organs","author":"Meigs","year":"1934"},{"issue":"3","key":"10.1016\/j.clcc.2024.05.007_bib0040","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF01274232","article-title":"Surgical management of peritoneal carcinosis: diagnosis, prevention and treatment","volume":"373","author":"Sugarbaker","year":"1988","journal-title":"Langenbecks Arch Chir"},{"issue":"3","key":"10.1016\/j.clcc.2024.05.007_bib0041","first-page":"101","article-title":"Prospective randomized trial of intravenous v intraperitoneal 5-FU in patients with advanced primary colon or rectal cancer","volume":"12","author":"Sugarbaker","year":"1985","journal-title":"Semin Oncol"},{"key":"10.1016\/j.clcc.2024.05.007_bib0042","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/978-1-4613-1247-5_20","article-title":"Treatment of peritoneal carcinomatosis from colon or appendiceal cancer with induction intraperitoneal chemotherapy","volume":"82","author":"Sugarbaker","year":"1996","journal-title":"Cancer Treat Res"},{"issue":"3","key":"10.1016\/j.clcc.2024.05.007_bib0043","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1055-3207(03)00037-1","article-title":"Quantitative prognostic indicators of peritoneal surface malignancy: carcinomatosis, sarcomatosis, and peritoneal mesothelioma","volume":"12","author":"Glehen","year":"2003","journal-title":"Surg Oncol Clin N Am"},{"issue":"472\u2013477","key":"10.1016\/j.clcc.2024.05.007_bib0044","first-page":"12","volume":"43","author":"Warrick","year":"1744","journal-title":"Philos Trans"},{"issue":"4","key":"10.1016\/j.clcc.2024.05.007_bib0045","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/17425247.2020.1736551","article-title":"Intraperitoneal chemotherapy for peritoneal metastases: an expert opinion","volume":"17","author":"Ceelen","year":"2020","journal-title":"Expert Opin Drug Deliv"},{"issue":"8","key":"10.1016\/j.clcc.2024.05.007_bib0046","first-page":"220","article-title":"Hypertherme Peritonealperfusion bei Aszitestumoren der Ratte [Hyperthermic peritoneal perfusion in ascites tumours in rats (author's transl)]","volume":"86","author":"Euler","year":"1974","journal-title":"Wien Klin Wochenschr"},{"issue":"1","key":"10.1016\/j.clcc.2024.05.007_bib0047","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1040-8428(01)00179-2","article-title":"The cellular and molecular basis of hyperthermia","volume":"43","author":"Hildebrandt","year":"2002","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"10.1016\/j.clcc.2024.05.007_bib0048","first-page":"2649","article-title":"The evaluation of thermal cisplatin sensitization in normal and XP human cells using mild hyperthermia at 40 and 41 degrees C","volume":"25","author":"Raaphorst","year":"2005","journal-title":"Anticancer Res"},{"issue":"4","key":"10.1016\/j.clcc.2024.05.007_bib0049","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/0277-5379(91)90389-U","article-title":"Optimisation of intraperitoneal cisplatin therapy with regional hyperthermia in rats","volume":"27","author":"Los","year":"1991","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.clcc.2024.05.007_bib0050","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/jso.21051","article-title":"Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy","volume":"98","author":"Kusamura","year":"2008","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.clcc.2024.05.007_bib0051","unstructured":"https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/colon.pdf."},{"issue":"1","key":"10.1016\/j.clcc.2024.05.007_bib0052","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","article-title":"Metastatic colorectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"34","author":"Cervantes","year":"2023","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.clcc.2024.05.007_bib0053","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1002\/cncr.32874","article-title":"The Chicago Consensus on peritoneal surface malignancies: management of colorectal metastases","volume":"126","author":"Chicago Consensus Working Group","year":"2020","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.clcc.2024.05.007_bib0054","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/bjs.11609","article-title":"Management of colorectal cancer metastases to the liver, lung or peritoneum suitable for curative intent: summary of NICE guidance","volume":"107","author":"Mohamed","year":"2020","journal-title":"Br J Surg"},{"issue":"17","key":"10.1016\/j.clcc.2024.05.007_bib0055","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.3390\/cancers14174275","article-title":"Comprehensive treatment algorithms of the Swiss peritoneal cancer group for peritoneal cancer of gastrointestinal origin","volume":"14","author":"Adamina","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clcc.2024.05.007_bib0056","unstructured":"https:\/\/register.awmf.org\/assets\/guidelines\/021-007OLl_S3_Kolorektales-Karzinom-KRK_2019-01.pdf. Accessed October, 2023."},{"key":"10.1016\/j.clcc.2024.05.007_bib0057","unstructured":"https:\/\/www.aco-asso.at\/wp\/wp-content\/uploads\/2013\/10\/Leitlinie-definitive-Finalversion-2.10.2013.pdf. Accessed October, 2023."},{"issue":"10","key":"10.1016\/j.clcc.2024.05.007_bib0058","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.dld.2019.05.035","article-title":"Metastatic colorectal cancer (mCRC): French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)","volume":"51","author":"Phelip","year":"2019","journal-title":"Dig Liver Dis"},{"issue":"3","key":"10.1016\/j.clcc.2024.05.007_bib0059","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1200\/JCO.22.01690","article-title":"Treatment of metastatic colorectal cancer: ASCO guideline","volume":"41","author":"Morris","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2024.05.007_bib0060","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejca.2016.10.007","article-title":"The relevance of primary tumour location in patients with metastatic colorectal cancer: a meta-analysis of first-line clinical trials","volume":"70","author":"Holch","year":"2017","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.clcc.2024.05.007_bib0061","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1245\/s10434-019-07255-5","article-title":"Does primary tumor side matter in patients with metastatic colon cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy?","volume":"26","author":"Kelly","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.clcc.2024.05.007_bib0062","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/cncr.29129","article-title":"Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease?","volume":"121","author":"Price","year":"2015","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.clcc.2024.05.007_bib0063","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/bjs5.50179","article-title":"Meta-analysis of prognostic factors for patients with colorectal peritoneal metastasis undergoing cytoreductive surgery and heated intraperitoneal chemotherapy","volume":"3","author":"Hallam","year":"2019","journal-title":"BJS Open"},{"issue":"3","key":"10.1016\/j.clcc.2024.05.007_bib0064","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1245\/s10434-021-10925-y","article-title":"Outcomes of combined peritoneal and local treatment for patients with peritoneal and limited liver metastases of colorectal origin: a systematic review and meta-analysis","volume":"29","author":"Polderdijk","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.clcc.2024.05.007_bib0065","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41416-021-01620-6","article-title":"Impact of KRAS, BRAF and microsatellite instability status after cytoreductive surgery and HIPEC in a national cohort of colorectal peritoneal metastasis patients","volume":"126","author":"Larsen","year":"2022","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.clcc.2024.05.007_bib0066","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1245\/s10434-021-10829-x","article-title":"Organoids as a robust preclinical model for precision medicine in colorectal cancer: a systematic review","volume":"29","author":"Flood","year":"2022","journal-title":"Ann Surg Oncol"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002824000379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002824000379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T16:08:28Z","timestamp":1732723708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002824000379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1533002824000379"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2024.05.007","relation":{},"ISSN":["1533-0028"],"issn-type":[{"value":"1533-0028","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peritoneal Carcinomatosis in Colorectal Cancer: Review and Update of Current Clinical Data","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2024.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}